Zhejiang Xinhecheng Pharmaceutical has been recognized as a 2025**-level specialized, innovative, and distinctive \"little giant\" enterprise

Thread Content

On January 8, 2026, the Shaoxing Municipal Party Committee’s economic work conference held an award ceremony; Zhejiang Xinhecheng Pharmaceutical Co., Ltd. was recognized as part of the **7th batch of specialized, innovative, and high-quality ‘little giant’ enterprises** thanks to its technological innovation capabilities and industrialization advantages. Qiu Jinzhuo, the company’s general manager, received the award on behalf of the company. The company focuses on the research, development, and production of nutritional products such as biotin and vitamin D3. It adheres to independent innovation, has made breakthroughs in multiple key manufacturing processes, holds over 50 invention patents, and has thus established significant technical barriers and industrial advantages. In the future, the company will focus on the fields of nutritional products and biomedicine, increase investment in research and development, improve efficiency in innovation and the translation of innovations into practical applications, and become a leader in its specific niche.